SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Form
Filing Date
Jun 7, 2024
Document Date
Jun 7, 2024
Form Description
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
Filing Group
Other
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC